ReviewNanomedicine (London, England)2022

Tumor-targeted miRNA nanomedicine for overcoming challenges in immunity and therapeutic resistance.

Neha N Parayath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.